#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14874	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2029	726.1	0	.	n	.	0	A69G	SNP	69	69	A	304	304	G	824	G,A	585,193	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14874	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2029	726.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1685	1685	T	828	T	764	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14874	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2029	726.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1419	1419	C	876	C	828	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27034	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3502	768.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1660	1660	A	895	A,G	843,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27034	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3502	768.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2294	2294	C	834	C	783	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27034	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3502	768.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2368	2368	A	817	A	778	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27034	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3502	768.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2920	2920	C	832	C	806	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	2110	folP	852	852	99.88	folP.l15.c4.ctg.1	1634	128.7	0	.	p	.	0	E151K	NONSYN	451	453	GAA	895	897	AAA	196;197;198	A;A;A	186;188;188	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	2110	folP	852	852	99.88	folP.l15.c4.ctg.1	1634	128.7	1	SNP	p	R228S	1	.	.	682	684	AGC	1126	1128	AGC	192;190;190	A;G;C	178;179;177	folP.WHO_K_01359c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5186	gyrA	2751	2751	99.89	gyrA.l6.c30.ctg.1	3433	150.7	0	.	p	.	0	K261del	DEL	781	781	A	1134	1134	A	167	A	160	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5186	gyrA	2751	2751	99.89	gyrA.l6.c30.ctg.1	3433	150.7	1	SNP	p	S91F	0	.	.	271	273	TCC	624	626	TCC	180;181;181	T;C;C	170;170;172	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5186	gyrA	2751	2751	99.89	gyrA.l6.c30.ctg.1	3433	150.7	1	SNP	p	D95G	0	.	.	283	285	GAC	636	638	GAC	171;169;168	G;A;C	161;158;158	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5186	gyrA	2751	2751	99.89	gyrA.l6.c30.ctg.1	3433	150.7	1	SNP	p	D95N	0	.	.	283	285	GAC	636	638	GAC	171;169;168	G;A;C	161;158;158	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1648	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1450	113.5	1	SNP	p	G45D	0	.	.	133	135	GGC	519	521	GGC	207;209;211	G,A;G,T;C	195,1;195,1;199	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	924	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1014	90.3	0	.	n	.	0	A197.	DEL	197	197	A	532	532	A	213	A	197	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4890	parC	2304	2304	99.91	parC.l6.c30.ctg.1	3074	158.5	1	SNP	p	D86N	0	.	.	256	258	GAC	636	638	GAC	224;222;225	G;A;C	210;202;208	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4890	parC	2304	2304	99.91	parC.l6.c30.ctg.1	3074	158.5	1	SNP	p	S87W	0	.	.	259	261	AGT	639	641	AGT	221;223;225	A,C;G;T	207,1;209;213	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4890	parC	2304	2304	99.91	parC.l6.c30.ctg.1	3074	158.5	1	SNP	p	S87R	0	.	.	259	261	AGT	639	641	AGT	221;223;225	A,C;G;T	207,1;209;213	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4890	parC	2304	2304	99.91	parC.l6.c30.ctg.1	3074	158.5	1	SNP	p	S87I	0	.	.	259	261	AGT	639	641	AGT	221;223;225	A,C;G;T	207,1;209;213	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4890	parC	2304	2304	99.91	parC.l6.c30.ctg.1	3074	158.5	1	SNP	p	S88P	0	.	.	262	264	TCC	642	644	TCC	225;225;225	T;C;C	209;212;210	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4398	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2797	156.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1622	1624	GGC	238;236;231	G;G;C	223;217;213	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4118	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2342	175.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1238	1240	GCA	228;229;227	G,A;C;A	210,1;211;213	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4118	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2342	175.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1241	1243	ATC	229;230;230	A,G;T;C	212,1;215;212	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4118	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2342	175.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1253	1255	GTG	230;227;230	G;T;G	215;213;215	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4118	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2342	175.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1253	1255	GTG	230;227;230	G;T;G	215;213;215	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4118	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2342	175.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1757	1759	ACC	209;208;207	A;C;C	188;192;193	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4118	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2342	175.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1811	1813	GCG	196;199;201	G;C;G	171;157;169	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4118	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2342	175.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1811	1813	GCG	196;199;201	G;C;G	171;157;169	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4118	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2342	175.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1934	1936	GGC	162;161;162	G;G;C	152;153;154	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4118	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2342	175.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1943	1945	GGC	159;158;156	G;G;C	142;145;146	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4118	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2342	175.1	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1961	1963	CTG	152;152;151	C,G;T;G	119,5;110;117	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6054	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3040	198.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1591	1593	CCG	231;232;236	C,T;C;G	199,1;216;211	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2142	porA	1146	1146	99.65	porA.l6.c17.ctg.1	1725	123.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	563	563	C	153	C	143	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	318	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	439	24.7	0	.	p	.	0	V258L	NONSYN	772	774	GTA	90	92	TTA	44;45;45	T;T;A	42;43;43	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	318	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	439	24.7	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	135	137	CAT	53;50;49	C;A;T	50;47;46	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	318	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	439	24.7	0	.	p	.	0	D274S	NONSYN	820	822	GAT	138	140	AGT	49;49;49	A;G;T	47;46;48	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	318	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	439	24.7	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	147	149	TAC	49;49;49	T;A;C	48;47;46	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	318	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	439	24.7	0	.	p	.	0	R307A	NONSYN	919	921	AGA	237	239	GCA	13;13;13	G;C;A	12;12;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	318	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	439	24.7	0	.	p	.	0	T311A	NONSYN	931	933	ACA	249	251	GCA	13;13;13	G;C;A	13;13;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	318	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	439	24.7	0	.	p	.	0	E312D	NONSYN	934	936	GAA	252	254	GAC	13;13;13	G;A;C	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	318	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	439	24.7	0	.	p	.	0	F314I	NONSYN	940	942	TTC	258	260	ATC	14;13;13	A;T;C	13;11;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	318	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	439	24.7	0	.	p	.	0	A316S	NONSYN	946	948	GCG	264	266	TCG	13;12;12	T;C;G	11;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	318	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	439	24.7	0	.	p	.	0	V318A	NONSYN	952	954	GTC	270	272	GCC	12;12;12	G;C;C	10;11;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	318	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	439	24.7	0	.	p	.	0	G319S	NONSYN	955	957	GGC	273	275	AGC	12;12;10	A;G;C	9;10;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	318	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	439	24.7	0	.	p	.	0	G320A	NONSYN	958	960	GGT	276	278	GCC	8;8;7	G;C;C	6;7;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	318	porB1a	984	271	91.51	porB1a.l15.c30.ctg.1	439	24.7	0	.	p	.	0	G322V	NONSYN	964	966	GGT	282	284	GTT	7;8;9	G;T;T	5;8;6	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2942	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1506	193.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	435	437	GAA	265;267;266	G;A;A	248;251;250	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2942	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1506	193.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	723	725	GAT	262;260;262	G;A;T,C	250;247;248,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2942	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1506	193.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	846	848	TCA	259;258;256	T;C;A	241;241;237	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2942	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1506	193.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	975	977	GTC	247;248;250	G;T;C	229;228;237	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2942	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1506	193.2	0	.	p	.	0	F222S	NONSYN	664	666	TTT	987	989	TCT	248;246;247	T;C;T	233;234;237	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2942	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1506	193.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1305	1307	GCA	203;206;208	G;C;A	192;194;197	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2942	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1506	193.2	1	SNP	p	G120K	1	.	.	358	360	AAG	681	683	AAG	263;268;268	A,C;A;G	253,1;258;257	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2942	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1506	193.2	1	SNP	p	D121N	0	.	.	361	363	GAC	684	686	GAC	268;268;269	G,C;A;C	253,1;254;257	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2942	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1506	193.2	1	SNP	p	A121D	1	.	.	361	363	GAC	684	686	GAC	268;268;269	G,C;A;C	253,1;254;257	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10848	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4870	222.1	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2054	2056	AAT	250;249;249	A;A;T	239;238;231	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1242	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1118	110.8	1	SNP	p	V57M	1	.	.	169	171	ATG	587	589	ATG	246;246;243	A;T;G	236;237;234	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
